- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this trial is to evaluate the safety and tolerability of a single intramuscular (IM) dose of AVI-4658, a phosphorodiamidate Morpholino oligomer (PMO) at increasing dosages compared to placebo in up to 9 DMD subjects divided into three groups.
Critère d'inclusion
- Duchenne Muscular Dystrophy